Vitamin D and cognitive impairment in the elderly U.S. population

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 1, 2011, Pages 59-65

  Llewellyn, David J ^a   Lang, Iain A ^a   Langa, Kenneth M ^b,c   Melzer, David ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognition; Cognitive impairment; Dementia; Serum 25 hydroxyvitamin D; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

AGED; ARTICLE; BLOOD; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; STATISTICAL MODEL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951623817     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq185     Document Type: Article

References (30)

1. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008;22(4):982-1001. (Pubitemid 351519955)
2. Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D" ecline? Mol Aspects Med. 2008;29(6):415-422.
3. Masoumi A, Goldenson B, Ghirmai S, et al. 1 Alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2009;17(3):703-717.
4. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin d concentration and cognitive impairment. J Geriatr Psychiatry Neurol. 2009;22(3):188-195.
5. Lee DM, Tajar A, Ulubaev A, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatr. 2009;80(7):722-729.
6. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci. 2009;64(8):888-895.
7. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic D. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology. 2007;29(1-2): 49-54. (Pubitemid 350191417)
8. Gunter EW, Lewis BL, Koncikowski SM. Laboratory Methods Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. 1996. Hyattsville, MD: Centers for Disease Control and Prevention.
9. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5):771-777. (Pubitemid 34468001)
10. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76(1):187-192. (Pubitemid 34686565)
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
12. Gfeller JD, Horn GJ. The East Boston Memory Test: a clinical screening measure for memory impairment in the elderly. J Clin Psychol. 1996;52(2):191-196. (Pubitemid 26174405)
13. Wechsler D. WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation; 1997.
14. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59(2):198-205. (Pubitemid 34779177)
15. Ganguli M, Belle S, Ratcliff G, et al. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES project. J Gerontol. 1993;48(4):M152-M161. (Pubitemid 23199255)
16. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry. 2003;60(2):198-203. (Pubitemid 36173127)
17. Llewellyn DJ, Lang IA, Langa KM, Naughton F, Matthews FE. Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement. BMJ. 2009;338: b462.
18. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292(12):1454-1461. (Pubitemid 39258338)
19. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
20. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28. (Pubitemid 44699167)
21. Lang IA, Llewellyn DJ, Langa KM, Wallace RB, Melzer D. Neighbourhood deprivation and incident mobility disability in older adults. Age Ageing. 2008;37(4):403-410. (Pubitemid 351965885)
22. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia. 2005;48(7):1247-1257. (Pubitemid 41186086)
23. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006;37(1):243-245. (Pubitemid 43732081)
24. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063-1069. (Pubitemid 351664326)
25. Hendrie HC, Albert MS, Butters MA, et al. The NIH cognitive and emotional health project: report of the critical evaluation study committee. Alzheimers Dement. 2006;2(1):12-32.
26. Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005;46(4):676-682. (Pubitemid 43186738)
27. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13(3):100-105. (Pubitemid 36733998)
28. Brown J, Bianco JI, McGrath JJ, Eyles DW. 1, 25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 2003;343(2):139-143. (Pubitemid 36577534)
29. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-2838. (Pubitemid 44969183)
30. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65(10):1348-1352.